Midwest Trust 13F: Cuts Stryker (SYK) Stake by $6.9M

Midwest Trust trimmed its holdings in Stryker Corporation by 24,891 shares, or 65.4%, according to a Form 13F filing with the SEC on October 22, 2026. The reduction left the institution holding 13,123 shares of the medical technology company with an estimated value of $3,613,929 at the end of the period.

SYK Stryker Corporation

$307.08 ▼ -11.05% year to date

1M 3M YTD

Daily close · Oct 22, 2026

What Changed in Midwest Trust's Stryker Corporation Position

Midwest Trust lowered its exposure to Stryker Corporation significantly during the quarter, bringing its prior stake of 38,014 shares down to 13,123 shares. The remaining shares were valued at $3,613,929 based on the values in the filing. Stryker Corporation closed at $307.08 on the day the filing was made public.

Other Institutional Activity in Stryker Corporation

Parnassus Investments grew its holdings by 120,008 shares, ending with 2,044,522 shares worth about $563,040,914. Greenleaf Trust reduced its holdings by 709,231 shares, ending with 15,228,545 shares worth about $4,676,381,394.

Stryker Corporation Stock Up 0.9%

Stryker Corporation shares recently traded around $307.15 on October 23, 2026, putting the stock about equal to its event-day close of $307.08. The stock sits roughly 3.3% above its 50-day moving average of $297.28, but remains 5.8% below its 200-day moving average of $325.90. Shares are down 21.8% from their 52-week high of $392.55 and up 15.0% from their 52-week low of $267.00.

Recent Earnings

Stryker Corporation reported trailing twelve month revenue of $25,837,000,704 alongside earnings of $9.65 per share. The company posted a net profit margin of 14.4% and a return on equity of 16.5%. The next quarterly earnings report is scheduled for October 29, 2026.

Dividend

Stryker Corporation pays an annual dividend of $3.52 per share, which translates to a dividend yield of 1.18%. The company maintains a dividend payout ratio of 36.1%, directing just over a third of its earnings back to shareholders through dividends.

Insider Buying and Selling at Stryker Corporation

Company insiders have completed several transactions over the past several months. Robert S Fletcher disposed of 4,544 shares on May 28, 2026, for a total value of $1,394,409. Debra King sold 826 shares at an average price of $336.30 on August 18, 2026, totaling $277,787. Ronda E Stryker sold 350,000 shares on August 19, 2026, with a total value of $117,776,128. Dylan Bram Crotty sold 441 shares at an average price of $328.60 on August 21, 2026, totaling $144,915.

Analysts Set New Price Targets

TD Cowen maintains a Hold rating with a target of $298.00 on September 22, 2026. Stifel maintains a Buy rating with a target of $330.00 on September 30, 2026. Truist Securities maintains a Hold rating with a target of $310.00 on October 7, 2026. Barclays initiated coverage with an Overweight rating and a $375.00 price target on October 7, 2026. BTIG maintains a Buy rating with a target of $316.00 on October 12, 2026. The stock holds a consensus Buy rating from 26 analysts with a mean price target of $362.62.

About Stryker Corporation

Stryker Corporation operates as a global medical technology company headquartered in Portage, Michigan. The firm designs and manufactures specialized medical equipment, devices, and surgical products across its MedSurg, Neurotechnology, and Orthopaedics segments, serving healthcare providers worldwide.

Bottom Line

Investors will look to the upcoming earnings release on October 29, 2026, for fresh insights into the company's financial health and segment performance. Institutional adjustments and insider transactions continue to shape market sentiment around the stock heading into the close of the year.